| Literature DB >> 34959771 |
Gesine Reinhardt1,2, Patrick Timpel1,2,3, Peter E H Schwarz1,2,4,5, Lorenz Harst3.
Abstract
As physical inactivity is one of the four leading risk factors for mortality, it should be intensively treated. Therefore, this one-year follow-up study aimed to evaluate the long-term effects of a preventive app to increase physical activity in German adults under real-life circumstances. Data collection took place from July 2019 to July 2021 and included six online questionnaires. Physical activity was studied as the primary outcome based on MET-minutes per week (metabolic equivalent). Secondary outcomes included health-related quality of life based on a mental (MCS) and physical health component summary score (PCS). At the time of publication, 46/65 participants completed the study (median 52 years, 81.5% women). A significant increase of physical activity was observed in people with a low/moderate baseline activity during the first four months of follow-up (median increase by 490 MET-minutes per week, p < 0.001, r = 0.649). Both MCS (median increase by 2.8, p = 0.006, r = 0.344) and PCS (median increase by 2.6, p < 0.001, r = 0.521) significantly increased during the first two months and the BMI significantly decreased during the first six months after the intervention (median decrease by 0.96 kg/m2, p < 0.001, r = 0.465). Thus, this study provides evidence for the medium-term impact of the app, since the effects decreased over time. However, due to the chosen study design and a sizeable loss to follow-up, the validity of these findings is limited.Entities:
Keywords: app; long-term effect; physical activity; prevention; sustainability
Mesh:
Year: 2021 PMID: 34959771 PMCID: PMC8707748 DOI: 10.3390/nu13124215
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Study concept: measurement points and methods. 1 other analogue or digital lifestyle interventions than “VIDEA bewegt”. Abbreviations: B0 = baseline; F0 = end of intervention; F2 = two months after the program; F4 = four months after the program; F6 = six months after the program; F12 = twelve months after the program; GPAQ = Global Physical Activity Questionnaire, MET = metabolic equivalent, SF-8 = Short Form Health Survey; PCS = Physical Component Summary Score; MCS = Mental Component Summary Score.
Characteristics of the study participants.
| Overall | 65 | |
|---|---|---|
|
| ||
| female | 81.5 | (53) |
| male | 18.5 | (12) |
|
| ||
| Mean, Median | 49 | 52 |
| 20–29 [%, ( | 12.3 | (8) |
| 30–39 [%, ( | 13.8 | (9) |
| 40–49 [%, ( | 18.5 | (12) |
| 50–59 [%, ( | 29.2 | (19) |
| 60–69 [%, ( | 21.5 | (14) |
| 70–79 [%, ( | 4.6 | (3) |
|
| ||
| Mean, Median [kg/m2] | 27.04 | 26.11 |
| Normal weight [%, ( | 45.3 | (29) |
| Overweight [%, ( | 25 | (16) |
| Obesity [%, ( | 29.7 | (19) |
|
| ||
| Married | 58.5 | (38) |
| Living in a stable relationship | 13.8 | (9) |
| Divorced or separated | 12.3 | (8) |
| Single | 10.8 | (7) |
| Widowed | 3.1 | (2) |
| Other | 1.5 | (1) |
|
| ||
| University degree | 38.5 | (25) |
| Completed vocational training | 32.3 | (21) |
| High school (12 years or more) | 10.8 | (7) |
| Secondary school (10 or 11 years) | 13.8 | (9) |
| Main school (9 years or less) | 1.5 | (1) |
| Other | 3.1 | (2) |
|
| ||
| Full-time | 46.2 | (30) |
| Half-time | 15.4 | (10) |
| Part-time | 7.7 | (5) |
| Not employed | 10.8 | (7) |
| Retired | 20 | (13) |
|
| ||
| Mean, Median | 136.7 | 87 |
|
| ||
| Health insurance | 53.8 | (35) |
| Doctor | 15.4 | (10) |
| Internet | 15.4 | (10) |
| Social environment | 13.9 | (9) |
| Others | 1.5 | (1) |
|
| 46.2 | (30) |
|
| 21.5 | (14) |
|
| ||
| AOK PLUS, AOK Rheinland/Hamburg 3 | 83.1 | (54) |
| Other statutory insurance 4 | 13.8 | (9) |
| Private insurance 4 | 3.1 | (2) |
1 about the app “VIDEA bewegt”; 2 interventions other than “VIDEA bewegt”; 3 German statutory insurances where users could participate in the app for free; 4 other German insurances where users had to pay 130€ in advance and were reimbursed part of the course cost after completing the program.
Development of MET-minutes per week, using Wilcoxon signed-rank test.
| B0 | F0 | F2 | F4 | F6 | F12 | ||
|---|---|---|---|---|---|---|---|
| all participants |
| 64 | 64 | 61 | 60 | 56 | 46 |
| Mean | 4680 | 5689 | 5090 | 4908 | 4876 | 3224 | |
| (SD) | (4938) | (6903) | (4933) | (4687) | (4613) | (3687) | |
| Median | 2640 | 3080 | 3840 | 3130 | 3560 | 2120 | |
| 25% quantile | 1470 | 1440 | 1720 | 1280 | 1070 | 840 | |
| 75% quantile | 6650 | 7440 | 6960 | 6570 | 8372 | 3630 | |
| Wilcoxon 1 | |||||||
|
| 0.150 | 0.242 | 0.515 | 0.766 | 0.032 | ||
| z | −1.441 | −1.171 | −0.650 | −0.297 | −2.147 | ||
| r | 0.180 | 0.150 | 0.084 | 0.040 | 0.317 | ||
| Wilcoxon 2 | |||||||
|
| 0.448 | 0.642 | 0.261 | 0.002 | |||
| z | −0.759 | −0.465 | −1.124 | −3.136 | |||
| r | 0.097 | 0.060 | 0.150 | 0.462 | |||
| <3000 MET−min/week at B0 |
| 34 | 33 | 33 | 32 | 30 | 26 |
| Mean | 1435 | 3141 | 3538 | 3084 | 2853 | 2005 | |
| (SD) | (799) | (4112) | (3439) | (3204) | (3017) | (1753) | |
| Median | 1560 | 1700 | 2760 | 1780 | 1730 | 1410 | |
| 25% quantile | 820 | 980 | 1080 | 1200 | 855 | 780 | |
| 75% quantile | 2040 | 3400 | 4540 | 3840 | 4005 | 3250 | |
| Wilcoxon 1 | |||||||
|
| <0.001 | <0.001 | <0.001 | 0.018 | 0.258 | ||
| z | −3.931 | −4.450 | −3.674 | −2.368 | −1.130 | ||
| r | 0.684 | 0.775 | 0.649 | 0.432 | 0.222 | ||
| Wilcoxon 2 | |||||||
|
| 0.352 | 0.902 | 0.432 | 0.124 | |||
| z | −0.931 | −0.123 | −0.786 | −1.537 | |||
| r | 0.162 | 0.022 | 0.144 | 0.301 | |||
| ≥3000 MET−min/week at B0 |
| 30 | 30 | 27 | 27 | 25 | 19 |
| Mean | 8357 | 8640 | 7159 | 7233 | 7461 | 5022 | |
| (SD) | (5091) | (8233) | (5770) | (5212) | (5006) | (4881) | |
| Median | 7060 | 7020 | 5180 | 5280 | 5280 | 3420 | |
| 25% quantile | 4390 | 3000 | 3360 | 3220 | 3572 | 2020 | |
| 75% quantile | 10,670 | 10,725 | 9240 | 10,080 | 11,370 | 7800 | |
| Wilcoxon 1 | |||||||
|
| 0.565 | 0.009 | 0.110 | 0.211 | <0.001 | ||
| z | −0.576 | −2.631 | −1.598 | −1.251 | −3.421 | ||
| r | 0.105 | 0.506 | 0.308 | 0.250 | 0.785 | ||
| Wilcoxon 2 | |||||||
|
| 0.088 | 0.692 | 0.264 | 0.005 | |||
| z | −1.706 | −0.396 | −1.117 | −2.817 | |||
| r | 0.328 | 0.076 | 0.223 | 0.646 | |||
| <3000 MET−min/week [% ( | 53.1 (34) | 48.4 (31) | 36.1 (22) | 45.0 (27) | 46.4 (26) | 58.7 (27) | |
| ≥3000 MET−min/week [% ( | 46.9 (30) | 51.6 (33) | 63.9 (39) | 55.0 (33) | 53.6 (30) | 41.3 (19) | |
1 asymptotic, two-sided Wilcoxon test between the baseline and subsequent measurement points; 2 asymptotic, two-sided Wilcoxon test between the end of intervention (F0) and the subsequent measurement points. Abbreviations: B0 = baseline; F0 = end of intervention; F2 = two months after the intervention; F4 = four months after the intervention; F6 = six months after the intervention; F12 = twelve months after the intervention; MET = metabolic equivalent; r = effect size.
Development of PCS, using Wilcoxon signed-rank test.
| B0 | F0 | F2 | F4 | F6 | F12 | |
|---|---|---|---|---|---|---|
|
| 65 | 65 | 65 | 61 | 58 | 45 |
| Mean | 47.24 | 50 | 51.41 | 48.71 | 49 | 48.31 |
| (SD) | (8.83) | (6.94) | (6.71) | (9.04) | (8.05) | (9.03) |
| Median | 49.74 | 50.48 | 52.34 | 51.11 | 50.16 | 48.92 |
| 25% quantile | 41.30 | 44.61 | 47.76 | 45.48 | 42.04 | 42.10 |
| 75% quantile | 53.30 | 55.46 | 56.68 | 55.89 | 55.86 | 56.96 |
| Wilcoxon 1 | ||||||
|
| 0.003 | <0.001 | 0.033 | 0.025 | 0.167 | |
| z | −2.623 | −4.197 | −2.133 | −2.241 | −1.383 | |
| r | 0.325 | 0.521 | 0.273 | 0.294 | 0.206 |
1 Wilcoxon signed-rank test between B0 and the follow-up measurements points. Abbreviations: B0 = baseline; F0 = end of intervention; F2 = two months after the intervention; F4 = four months after the intervention; F6 = six months after the intervention; F12 = twelve months after the intervention; PCS = Physical Component Summary Score; r = effect size.
Development of MCS, using Wilcoxon signed-rank test.
| B0 | F0 | F2 | F4 | F6 | F12 | |
|---|---|---|---|---|---|---|
|
| 65 | 65 | 65 | 61 | 58 | 45 |
| Mean | 47.22 | 51.59 | 50.28 | 49.25 | 48.78 | 45.4 |
| (SD) | (9.05) | (8.23) | (7.86) | (10.02) | (9.74) | (10.04) |
| Median | 48.30 | 52.55 | 51.10 | 52.31 | 49.87 | 46.70 |
| 25% quantile | 41.57 | 48.01 | 47.88 | 44.01 | 43.42 | 40.35 |
| 75% quantile | 53.50 | 57.48 | 56.88 | 57.48 | 57.10 | 51.98 |
| Wilcoxon 1 | ||||||
|
| <0.001 | 0.006 | 0.054 | 0.027 | 0.800 | |
| z | −3.676 | −2.773 | −1.952 | −2.210 | −0.254 | |
| r | 0.456 | 0.344 | 0.250 | 0.290 | 0.038 |
1 Wilcoxon signed-rank test between B0 and the follow-up measurements points. Abbreviations: B0 = baseline; F0 = end of intervention; F2 = two months after the intervention; F4 = four months after the intervention; F6 = six months after the intervention; F12 = twelve months after the intervention; MCS = Mental Component Summary Score; r = effect size.
Development of the BMI, using Wilcoxon signed-rank test.
| B0 | F0 | F2 | F4 | F6 | F12 | |
|---|---|---|---|---|---|---|
|
| 64 | 64 | 63 | 60 | 57 | 46 |
| Mean | 27.04 (5.61) | 26.57 (5.38) | 26.56 (5.17) | 26.45 (5.25) | 26.31 (5.01) | 26.06 (4.92) |
| (SD) | ||||||
| Median | 26.12 | 24.91 | 25.38 | 25.44 | 25.16 | 24.85 |
| 25% quantile | 22.55 | 22.52 | 22.59 | 22.16 | 22.50 | 24.85 |
| 75% quantile | 31.22 | 30.59 | 30.10 | 29.75 | 29.34 | 30.12 |
| Wilcoxon 1 | ||||||
|
| <0.001 | <0.001 | 0.002 | <0.001 | 0.624 | |
| z | −3.530 | −3.794 | −3.169 | −3.514 | −0.490 | |
| r | 0.441 | 0.478 | 0.409 | 0.465 | 0.072 |
1 Wilcoxon signed-rank test between B0 and the follow-up measurements points. Abbreviations: B0 = baseline; F0 = end of intervention; F2 = two months after the intervention; F4 = four months after the intervention; F6 = six months after the intervention, F12 = twelve months after the intervention; SD = standard deviation; r = effect size.
Active minutes per day in the domain’s work, transport, and leisure time.
| B0 | F0 | F2 | F4 | F6 | F12 | ||
|---|---|---|---|---|---|---|---|
| Work |
| 64 | 64 | 61 | 60 | 56 | 46 |
| Mean | 70.35 | 74.97 | 76.16 | 76.58 | 77.70 | 48.78 | |
| (SD) | (95.68) | (105.24) | (106.14) | (108.83) | (108.83) | (74.21) | |
| Median | 19.64 | 27.86 | 40.00 | 41.43 | 29.29 | 17.14 | |
| 25% quantile | 0.00 | 0.00 | 7.86 | 5.71 | 0.00 | 0.00 | |
| 75% quantile | 122.14 | 102.86 | 124.29 | 128.57 | 106.07 | 72.86 | |
| Wilcoxon 1 | |||||||
|
| 0.571 | 0.589 | 0.229 | 0.971 | 0.190 | ||
| z | −0.566 | −0.541 | −1.204 | −0.036 | −1.312 | ||
| r | 0.070 | 0.069 | 0.155 | 0.005 | 0.193 | ||
| MWU 2 | |||||||
|
| 0.113 | 0.459 | 0.616 | 0.400 | 0.382 | 0.820 | |
| z | −1.586 | −0.741 | −0.502 | −0.842 | −0.874 | −0.228 | |
| r | 0.198 | 0.092 | 0.062 | 0.109 | 0.117 | 0.034 | |
| MWU 3 | |||||||
|
| 0.108 | 0.020 | 0.913 | 0.859 | 0.052 | 0.029 | |
| z | −1.608 | −0.317 | −0.109 | −0.177 | −1.944 | −2.182 | |
| r | 0.201 | 0.290 | 0.014 | 0.023 | 0.260 | 0.322 | |
| Transport |
| 64 | 64 | 61 | 60 | 56 | 46 |
| Mean | 24.50 | 26.92 | 27.49 | 24.88 | 32.39 | 20.59 | |
| (SD) | (31.43) | (32.40) | (26.34) | (24.53) | (34.13) | (23.77) | |
| Median | 15.71 | 17.14 | 25.00 | 17.14 | 21.43 | 15.71 | |
| 25% quantile | 0.00 | 6.43 | 6.43 | 8.57 | 7.50 | 2.14 | |
| 75% quantile | 30.00 | 42.14 | 37.14 | 38.93 | 48.21 | 30.00 | |
| Wilxocon 1 | |||||||
|
| 0.350 | 0.115 | 0.272 | 0.099 | 0.243 | ||
| z | −0.934 | −1.576 | −1.100 | −1.651 | −1.243 | ||
| r | 0.117 | 0.202 | 0.142 | 0.221 | 0.183 | ||
| MWU 2 | |||||||
|
| 0.507 | 0.015 | 0.956 | 0.233 | 0.267 | 0.709 | |
| z | −0.663 | −2.421 | −0.055 | −1.192 | −1.110 | −0.381 | |
| r | 0.083 | 0.303 | 0.007 | 0.154 | 0.148 | 0.027 | |
| MWU 3 | |||||||
|
| 0.078 | 0.838 | 0.590 | 0.055 | 0.534 | 0.427 | |
| z | −1.761 | −0.204 | −0.539 | −1.920 | −0.621 | −0.795 | |
| r | 0.220 | 0.026 | 0.070 | 0.248 | 0.083 | 0.117 | |
| Leisure time |
| 64 | 64 | 61 | 60 | 56 | 46 |
| Mean | 34.33 | 53.30 | 46.49 | 40.65 | 38.80 | 27.42 | |
| (SD) | (34.02) | (69.20) | (40.99) | (38.54) | (44.84) | (26.28) | |
| Median | 25.71 | 32.86 | 34.29 | 25.71 | 25.71 | 18.21 | |
| 25% quantile | 12.86 | 17.14 | 17.14 | 12.86 | 13.21 | 10.71 | |
| 75% quantile | 38.57 | 64.29 | 62.86 | 59.64 | 42.86 | 34.29 | |
| Wilxocon 1 | |||||||
|
| 0.011 | 0.011 | 0.068 | 0.182 | 0.385 | ||
| z | −2.533 | 2.547 | −1.828 | −1.335 | −0.869 | ||
| r | 0.317 | 0.326 | 0.236 | 0.178 | 0.128 | ||
| MWU 2 | |||||||
|
| 0.439 | 0.005 | 0.305 | 0.117 | 0.255 | 0.086 | |
| z | −0.773 | −2.838 | −1.026 | −1.568 | −1.139 | −1.716 | |
| r | 0.097 | 0.355 | 0.131 | 0.202 | 0.152 | 0.253 | |
| MWU 3 | |||||||
|
| 0.143 | 0.517 | 0.136 | 0.015 | 0.577 | 0.020 | |
| z | −1.465 | −0.648 | −1.492 | −2.520 | −0.558 | −2.329 | |
| r | 0.183 | 0.081 | 0.191 | 0.325 | 0.075 | 0.343 |
1 Wilcoxon signed-rank test between B0 and the follow-up measurements points; 2 Mann-Whitney-U test distinguishing whether the respective measurement point fell in a time period with high incidences of COVID-19 or not. High incidences appeared in March to April 2020 and November 2020 to February 2021 (these were also the months with the greatest restrictions on public live in Germany); 3 Mann-Whitney-U test distinguishing whether the respective measurement point fell into the cold or warm season. The cold season was defined as the period from 22 September to 19 March, and the warm season from 20 March to 21 September. Abbreviations: B0 = baseline; F0 = end of intervention; F2 = two months after the intervention; F4 = four months after the intervention; F6 = six months after the intervention; F12 = twelve months after the intervention; r = effect size.
Sedentary time per day in hours.
| B0 | F0 | F2 | F4 | F6 | F12 | |
|---|---|---|---|---|---|---|
|
| 64 | 64 | 61 | 60 | 56 | 46 |
| Mean | 6.52 | 5.89 | 5.66 | 5.71 | 6.26 | 6.72 |
| (SD) | (3.37) | (3.35) | (2.95) | (3.08) | (3.36) | (3.22) |
| Median | 6.00 | 5.00 | 5.00 | 5.00 | 5.00 | 6.00 |
| 25% quantile | 4.00 | 3.00 | 4.00 | 3.13 | 4.00 | 4.00 |
| 75% quantile | 8.00 | 8.00 | 7.00 | 8.00 | 8.38 | 9.00 |
| Wilcoxon 1 | ||||||
|
| 0.013 | 0.069 | 0.022 | 0.345 | 0.482 | |
| z | −2.472 | −1.818 | −2.213 | −0.944 | −0.703 | |
| r | 0.309 | 0.233 | 0.286 | 0.126 | 0.104 |
1 = Wilcoxon signed-rank test between B0 and the follow-up measurements points. Abbreviations: B0 = baseline; F0 = end of intervention; F2 = two months after the intervention; F4 = four months after the intervention; F6 = six months after the intervention; F12 = twelve months after the intervention; r = effect size.
Figure 2Motivation for long-term usage of app components at the end of the intervention. Notes: presentation in percentages.
Figure 3Sustained use of exercises contained in the training videos. Notes: Presentation in numbers of participants. Abbreviations: F2 = two months after the intervention; F4 = four months after the intervention; F6 = six months after the intervention; F12 = twelve months after the intervention.
Figure 4Sustained use of practical tips contained in videos of the app. Notes: Presentation in numbers of participants. Abbreviations: F2 = two months after the intervention; F4 = four months after the intervention; F6 = six months after the intervention; F12 = twelve months after the intervention.
Figure 5Application of different components of the rubric “my focus”. Abbreviations: F2 = two months after the intervention; F4 = four months after the intervention; F6 = six months after the intervention; F12 = twelve months after the intervention.
Figure 6Long-term improvement of health knowledge due to “VIDEA bewegt”. Notes: Presentation in numbers of participants. Abbreviations: F2 = two months after the intervention, F4 = four months after the intervention, F6 = six months after the intervention, F12 = twelve months after the intervention.
Spearman-Rho Test for measuring correlations: Influence of different factors on physical activity (MET-minutes per week) at the follow-up measurement points.
| Independent Factor | F0 | F2 | F4 | F6 | F12 | |
|---|---|---|---|---|---|---|
| Course duration | r | 0.295 | 0.213 | 0.016 | 0.167 | 0.172 |
|
| 0.018 | 0.099 | 0.904 | 0.218 | 0.252 | |
|
| 64 | 61 | 60 | 56 | 46 | |
| Motivation training videos F0 | r | 0.176 | 0.179 | 0.349 | 0.291 | 0.129 |
|
| 0.165 | 0.169 | 0.006 | 0.030 | 0.394 | |
|
| 64 | 61 | 60 | 56 | 46 | |
| Motivation “my focus” F0 | r | 0.258 | 0.243 | 0.390 | 0.356 | 0.294 |
|
| 0.040 | 0.059 | 0.002 | 0.007 | 0.047 | |
|
| 64 | 61 | 60 | 56 | 46 | |
| Motivation “practical tips” F0 | r | 0.128 | 0.072 | 0.255 | 0.173 | 0.159 |
|
| 0.313 | 0.582 | 0.050 | 0.201 | 0.292 | |
|
| 64 | 61 | 60 | 56 | 46 | |
| Usage training videos FX | r | 0.279 | 0.390 | 0.528 | 0.355 | |
|
| 0.029 | 0.006 | 0.000 | 0.015 | ||
|
| 61 | 60 | 55 | 46 | ||
| Usage practical tips FX | r | 0.206 | 0.074 | −0.028 | 0.138 | |
|
| 0.110 | 0.580 | 0.837 | 0.362 | ||
|
| 61 | 59 | 55 | 46 |
Abbreviations: F0 = end of intervention; F2 = two months after the intervention; F4 = four months after the intervention; F6 = six months after the intervention; F12 = twelve months after the intervention; FX = respective measurement point; r = correlation coefficient.
Spearman-Rho Test for measuring correlations: Influence of different factors on the effect of the app on the physical activity (MET-minutes per week) between B0 and the following measurement points.
| Independent Factor | ΔB0-F0 | ΔB0-F2 | ΔB0-F4 | ΔB0-F6 | ΔB0-F12 | |
|---|---|---|---|---|---|---|
| Course duration | r | 0.085 | −0.192 | −0.270 | −0.042 | −0.196 |
|
| 0.505 | 0.143 | 0.039 | 0.763 | 0.196 | |
|
| 63 | 60 | 59 | 55 | 45 | |
| Motivation training videos F0 | r | −0.045 | −0.072 | 0.140 | 0.028 | −0.133 |
|
| 0.724 | 0.585 | 0.292 | 0.839 | 0.385 | |
|
| 63 | 60 | 59 | 55 | 45 | |
| Motivation “my focus” F0 | r | 0.014 | −0.036 | 0.088 | 0.081 | −0.068 |
|
| 0.915 | 0.784 | 0.505 | 0.556 | 0.655 | |
|
| 63 | 60 | 59 | 55 | 45 | |
| Motivation “practical tips” F0 | r | −0.069 | −0.070 | −0.027 | −0.047 | −0.006 |
|
| 0.591 | −0.594 | 0.837 | 0.734 | 0.967 | |
|
| 63 | 60 | 59 | 55 | 45 | |
| Usage training videos FX | r | −0.193 | 0.051 | 0.108 | 0.038 | |
|
| 0.140 | 0.699 | 0.439 | 0.806 | ||
|
| 60 | 59 | 54 | 45 | ||
| Usage practical tips FX | r | −0.080 | 0.070 | −0.120 | 0.241 | |
|
| 0.542 | 0.600 | 0.388 | 0.111 | ||
|
| 60 | 58 | 54 | 45 |
Abbreviations: B0 = baseline; F0 = end of intervention; F2 = two months after the intervention; F4 = four months after the intervention; F6 = six months after the intervention; F12 = twelve months after the intervention; Δ = difference between two measurement points; FX = respective measurement point; r = correlation coefficient; PCS = Physical Component Summary Score; MCS = Mental Component Summary Score.
Spearman-Rho Test for measuring correlations: Influence of different factors on the effect of the app on the BMI between B0 and the following measurement points.
| Independent Factor | ΔB0-F0 | ΔB0-F2 | ΔB0-F4 | ΔB0-F6 | ΔB0-F12 | |
|---|---|---|---|---|---|---|
| Course duration | r | 0.021 | 0.055 | 0.171 | 0.228 | 0.066 |
|
| 0.872 | 0.666 | 0.191 | 0.088 | 0.663 | |
|
| 64 | 63 | 58 | 57 | 46 | |
| Motivation training videos F0 | r | 0.000 | −0.130 | −0.187 | −0.160 | −0.074 |
|
| 1.000 | 0.309 | 0.152 | 0.235 | 0.624 | |
|
| 64 | 63 | 60 | 57 | 46 | |
| Motivation “my focus” F0 | r | −0.139 | −0.269 | −0.277 | −0.215 | −0.059 |
|
| 0.272 | 0.033 | 0.032 | 0.109 | 0.696 | |
|
| 64 | 63 | 60 | 57 | 46 | |
| Motivation “practical tips” F0 | r | −0.177 | −0.290 | −0.291 | −0.266 | −0.150 |
|
| 0.162 | 0.021 | 0.024 | 0.046 | 0.320 | |
|
| 64 | 63 | 60 | 57 | 46 | |
| Usage training videos FX | r | −0.160 | −0.258 | −0.447 | −0.160 | |
|
| 0.209 | 0.048 | 0.001 | 0.288 | ||
|
| 63 | 60 | 56 | 46 | ||
| Usage practical tips FX | r | −0.298 | −0.203 | −0.359 | −0.107 | |
|
| 0.018 | 0.123 | 0.007 | 0.479 | ||
|
| 63 | 59 | 56 | 46 |
Abbreviations: B0 = baseline; F0 = end of intervention; F2 = two months after the intervention; F4 = four months after the intervention; F6 = six months after the intervention; F12 = twelve months after the intervention; Δ = difference between two measurement points; FX = respective measurement point; r = correlation coefficient; PCS = Physical Component Summary Score; MCS = Mental Component Summary Score.
Spearman-Rho Test for measuring correlations: Influence of different factors on the effect of the app on the BMI at the measurement points.
| Independent Factor | F0 | F2 | F4 | F6 | F12 | |
|---|---|---|---|---|---|---|
| Course duration | r | 0.036 | 0.038 | 0.010 | 0.030 | −0.056 |
|
| 0.776 | 0.767 | 0.939 | 0.825 | 0.712 | |
|
| 64 | 63 | 60 | 57 | 46 | |
| Motivation training videos F0 | r | 0.060 | 0.050 | 0.048 | 0.030 | 0.026 |
|
| 0.638 | 0.694 | 0.714 | 0.827 | 0.862 | |
|
| 64 | 63 | 60 | 57 | 46 | |
| Motivation “my focus” F0 | r | 0.222 | 0.210 | 0.227 | 0.227 | 0.286 |
|
| 0.078 | 0.099 | 0.081 | 0.089 | 0.054 | |
|
| 64 | 63 | 60 | 57 | 46 | |
| Motivation “practical tips” F0 | r | 0.178 | 0.164 | 0.190 | 0.190 | 0.140 |
|
| 0.159 | 0.199 | 0.146 | 0.158 | 0.353 | |
|
| 64 | 63 | 60 | 57 | 46 | |
| Usage training videos FX | r | 0.232 | 0.130 | 0.213 | 0.452 | |
|
| 0.067 | 0.322 | 0.114 | 0.002 | ||
|
| 63 | 60 | 56 | 46 | ||
| Usage practical tips FX | r | 0.182 | −0.015 | 0.161 | 0.061 | |
|
| 0.153 | 0.907 | 0.237 | 0.688 | ||
|
| 63 | 59 | 56 | 46 |
Abbreviations: F0 = end of intervention; F2 = two months after the intervention; F4 = four months after the intervention; F6 = six months after the intervention; F12 = twelve months after the intervention; FX = respective measurement point; r = correlation coefficient; PCS = Physical Component Summary Score; MCS = Mental Component Summary Score.
Mann-Whiney-U test: Influence of different factors on the effect of the app on the physical activity at the different measurement points.
| Variable | Group Variable |
| Middle Rank |
| z | r |
|---|---|---|---|---|---|---|
| MET-min/Wo F0 | Prepayment 130€ | 11 | 19.05 | 0.008 | −2.634 | 0.329 |
| No costs | 53 | 35.29 | ||||
| Usage of other health apps | 14 | 31.04 | 0.739 | −0.333 | 0.042 | |
| No other health apps | 50 | 32.91 | ||||
| Other health courses 1 | 32 | 34.09 | 0.493 | −0.685 | 0.086 | |
| No other health courses 1 | 32 | 30.91 | ||||
| During high COVID incidences 2 | 36 | 36.13 | 0.169 | −1.374 | 0.172 | |
| Outside high COVID incidences 2 | 28 | 29.68 | ||||
| MET-min/Wo F2 | Prepayment 130€ | 10 | 20.60 | 0.042 | −2.026 | 0.259 |
| No costs | 51 | 33.04 | ||||
| Usage of other health apps | 12 | 30.38 | 0.892 | −0.136 | 0.017 | |
| No other health apps | 49 | 31.15 | ||||
| Other health courses 1 | 29 | 31.33 | 0.891 | −0.137 | 0.018 | |
| No other health courses 1 | 32 | 30.70 | ||||
| During high COVID incidences 2 | 12 | 31.29 | 0.949 | −0.064 | 0.008 | |
| Outside high COVID incidences 2 | 49 | 30.93 | ||||
| MET-min/Wo F4 | Prepayment 130€ | 11 | 14.09 | <0.001 | −3.362 | 0.441 |
| No costs | 47 | 33.11 | ||||
| Usage of other health apps | 11 | 28.09 | 0.758 | −0.307 | 0.040 | |
| No other health apps | 47 | 29.83 | ||||
| Other health courses 1 | 20 | 27.63 | 0.540 | −0.614 | 0.081 | |
| No other health courses 1 | 38 | 30.49 | ||||
| During high COVID incidences 2 | 18 | 26.28 | 0.330 | −0.975 | 0.128 | |
| Outside high COVID incidences 2 | 40 | 30.95 | ||||
| MET-min/Wo F6 | Prepayment 130€ | 11 | 16.09 | 0.008 | −2.632 | 0.362 |
| No costs | 42 | 29.86 | ||||
| Usage of other health apps | 10 | 27.20 | 0.964 | −0.045 | 0.006 | |
| No other health apps | 43 | 26.95 | ||||
| Other health courses 1 | 22 | 25.89 | 0.658 | −0.442 | 0.061 | |
| No other health courses 1 | 31 | 27.79 | ||||
| During high COVID incidences 2 | 15 | 21.03 | 0.077 | −1.767 | 0.243 | |
| Outside high COVID incidences 2 | 38 | 29.36 | ||||
| MET-min/Wo F12 | Prepayment 130€ | 9 | 12.94 | 0.043 | −2.026 | 0.329 |
| No costs | 29 | 21.53 | ||||
| Usage of other health apps | 10 | 16.30 | 0.302 | −1.061 | 0.172 | |
| No other health apps | 28 | 20.64 | ||||
| Other health courses 1 | 10 | 20.25 | 0.804 | −0.249 | 0.040 | |
| No other health courses 1 | 28 | 19.23 | ||||
| During high COVID incidences 2 | 14 | 16.29 | 0.180 | −0.173 | 0.028 | |
| Outside high COVID incidences 2 | 24 | 21.38 |
Notes: 1 = Other health courses within the last six months at the time of baseline; 2 = High incidences appeared in March to April 2020 and November 2020 to February 2021. Abbreviations: F0 = end of intervention; F2 = two months after the intervention; F4 = four months after the intervention; F6 = six months after the intervention; F12 = twelve months after the intervention; Δ = difference between two measurement points.
Mann-Whiney-U test: Influence of different factors on the effect of the app on the physical activity between the different measurement points and B0.
| Variable | Group Variable |
| Middle Rank |
| z | r |
|---|---|---|---|---|---|---|
| Δ MET-min/Wo B0-F0 | Prepayment 130€ | 10 | 28.20 | 0.475 | −0.715 | 0.090 |
| No costs | 53 | 32.72 | ||||
| Usage of other health apps | 14 | 28.86 | 0.467 | −0.727 | 0.090 | |
| No other health apps | 49 | 32.90 | ||||
| Other health courses 1 | 32 | 32.36 | 0.874 | −0.158 | 0.020 | |
| No other health courses 1 | 31 | 31.63 | ||||
| During high COVID incidences 2 | 27 | 30.41 | 0.550 | −0.597 | 0.075 | |
| Outside high COVID incidences 2 | 36 | 33.19 | ||||
| Δ MET-min/Wo | Prepayment 130€ | 9 | 37.56 | 0.189 | −1.315 | 0.170 |
| B0-F2 | No costs | 51 | 29.25 | |||
| Usage of other health apps | 12 | 24.46 | 0.180 | −1.340 | 0.173 | |
| No other health apps | 48 | 32.01 | ||||
| Other health courses 1 | 29 | 32.09 | 0.496 | −0.681 | 0.064 | |
| No other health courses 1 | 31 | 29.02 | ||||
| During high COVID incidences 2 | 12 | 23.88 | 0.142 | −1.469 | 0.190 | |
| Outside high COVID incidences 2 | 48 | 32.16 | ||||
| Δ MET-min/Wo | Prepayment 130€ | 10 | 24.70 | 0.367 | −0.902 | 0.119 |
| B0-F4 | No costs | 47 | 29.91 | |||
| Usage of other health apps | 11 | 22.18 | 0.129 | −1.517 | 0.201 | |
| No other health apps | 46 | 30.63 | ||||
| Other health courses 1 | 20 | 27.43 | 0.598 | −0.527 | 0.070 | |
| No other health courses 1 | 37 | 29.85 | ||||
| During high COVID incidences 2 | 18 | 23.47 | 0.088 | −1.708 | 0.226 | |
| Outside high COVID incidences 2 | 39 | 31.55 | ||||
| Δ MET-min/Wo | Prepayment 130€ | 10 | 24.70 | 0.157 | −1.416 | 0.196 |
| B0-F6 | No costs | 42 | 26.93 | |||
| Usage of other health apps | 10 | 20.40 | 0.676 | −0.418 | 0.058 | |
| No other health apps | 42 | 27.95 | ||||
| Other health courses 1 | 22 | 28.36 | 0.448 | −0.759 | 0.105 | |
| No other health courses 1 | 30 | 25.13 | ||||
| During high COVID incidences 2 | 15 | 25.30 | 0.716 | −0.364 | 0.033 | |
| Outside high COVID incidences 2 | 37 | 26.99 | ||||
| Δ MET-min/Wo | Prepayment 130€ | 8 | 18.19 | 0.814 | −0.240 | 0.039 |
| B0-F12 | No costs | 29 | 19.22 | |||
| Usage of other health apps | 10 | 13.95 | 0.084 | −1.727 | 0.284 | |
| No other health apps | 27 | 20.87 | ||||
| Other health courses 1 | 10 | 21.25 | 0.448 | −0.770 | 0.127 | |
| No other health courses 1 | 27 | 18.17 | ||||
| During high COVID incidences 2 | 14 | 20.64 | 0.486 | −0.720 | 0.118 | |
| Outside high COVID incidences 2 | 23 | 18.00 |
Notes: 1 = Other health courses within the last six months at the time of baseline; 2 = High incidences appeared in March to April 2020 and November 2020 to February 2021. Abbreviations: B0 = baseline; F0 = end of intervention; F2 = two months after the intervention; F4 = four months after the intervention; F6 = six months after the intervention; F12 = twelve months after the intervention; Δ = difference between two measurement points.
Mann-Whiney-U test: Influence of different factors on the effect of the app on the BMI at the different measurement points.
| Variable | Group Variable |
| Middle Rank |
| z | r |
|---|---|---|---|---|---|---|
| BMI F0 | Prepayment 130€ | 11 | 31.91 | 0.908 | −0.116 | 0.015 |
| No costs | 53 | 32.62 | ||||
| Usage of other health apps | 14 | 33.32 | 0.852 | −0.187 | 0.023 | |
| No other health apps | 50 | 32.27 | ||||
| Other health courses 1 | 32 | 31.89 | 0.793 | −0.262 | 0.033 | |
| No other health courses 1 | 32 | 33.11 | ||||
| During high COVID incidences 2 | 29 | 36.93 | 0.083 | −1.733 | 0.217 | |
| Outside high COVID incidences 2 | 35 | 28.83 | ||||
| BMI F2 | Prepayment 130€ | 11 | 31.91 | 0.986 | −0.018 | 0.002 |
| No costs | 52 | 32.02 | ||||
| Usage of other health apps | 14 | 32.25 | 0.954 | −0.058 | 0.007 | |
| No other health apps | 49 | 31.93 | ||||
| Other health courses 1 | 30 | 31.82 | 0.94 | −0.076 | 0.010 | |
| No other health courses 1 | 33 | 32.17 | ||||
| During high COVID incidences 2 | 14 | 33.86 | 0.667 | −0.430 | 0.054 | |
| Outside high COVID incidences 2 | 49 | 31.47 | ||||
| BMI F4 | Prepayment 130€ | 11 | 29.98 | 0.937 | −0.079 | 0.010 |
| No costs | 47 | 29.41 | ||||
| Usage of other health apps | 11 | 32.09 | 0.572 | −0.565 | 0.074 | |
| No other health apps | 47 | 28.89 | ||||
| Other health courses 1 | 21 | 26.69 | 0.34 | −0.955 | 0.125 | |
| No other health courses 1 | 37 | 31.09 | ||||
| During high COVID incidences 2 | 17 | 24.21 | 0.124 | −1.537 | 0.202 | |
| Outside high COVID incidences 2 | 41 | 31.70 | ||||
| BMI F6 | Prepayment 130€ | 11 | 28.68 | 0.78 | −0.279 | 0.038 |
| No costs | 43 | 27.20 | ||||
| Usage of other health apps | 10 | 27.35 | 0.973 | −0.033 | 0.132 | |
| No other health apps | 44 | 27.53 | ||||
| Other health courses 1 | 23 | 26.57 | 0.707 | −0.376 | 0.051 | |
| No other health courses 1 | 31 | 28.19 | ||||
| During high COVID incidences 2 | 15 | 28.97 | 0.671 | −0.425 | 0.058 | |
| Outside high COVID incidences 2 | 39 | 26.94 | ||||
| BMI F12 | Prepayment 130€ | 9 | 19.41 | 0.932 | −0.086 | 0.014 |
| No costs | 29 | 19.78 | ||||
| Usage of other health apps | 10 | 19.80 | 0.935 | −0.099 | 0.016 | |
| No other health apps | 28 | 19.39 | ||||
| Other health courses 1 | 10 | 16.10 | 0.260 | −1.127 | 0.183 | |
| No other health courses 1 | 28 | 20.71 | ||||
| During high COVID incidences 2 | 14 | 17.86 | 0.486 | −0.696 | 0.113 | |
| Outside high COVID incidences 2 | 24 | 20.46 |
Notes: 1 = Other health courses within the last six months at the time of baseline; 2 = High incidences appeared in March to April 2020 and November 2020 to February 2021. Abbreviations: B0 = baseline; F0 = end of intervention; F2 = two months after the intervention; F4 = four months after the intervention; F6 = six months after the intervention; F12 = twelve months after the intervention; Δ = difference between two measurement points.
Mann-Whiney-U test: Influence of different factors on the effect of the app on the BMI between the different measurement points and B0.
| Variable | Group Variable |
| Middle Rank |
| z | r |
|---|---|---|---|---|---|---|
| Δ BMI B0-F0 | Prepayment 130€ | 11 | 35.64 | 0.533 | −0.624 | 0.078 |
| No costs | 53 | 31.85 | ||||
| Usage of other health apps | 14 | 29.82 | 0.536 | −0.619 | 0.077 | |
| No other health apps | 50 | 33.23 | ||||
| Other health courses 1 | 32 | 32.97 | 0.838 | −0.205 | 0.026 | |
| No other health courses 1 | 32 | 32.03 | ||||
| During high COVID incidences 2 | 29 | 28.78 | 0.139 | −0.479 | 0.060 | |
| Outside high COVID incidences 2 | 35 | 35.59 | ||||
| Δ BMI B0-F2 | Prepayment 130€ | 11 | 33.73 | 0.729 | −0.347 | 0.044 |
| No costs | 52 | 31.63 | ||||
| Usage of other health apps | 14 | 28.25 | 0.381 | −0.875 | 0.110 | |
| No other health apps | 49 | 33.07 | ||||
| Other health courses 1 | 30 | 31.78 | 0.928 | −0.090 | 0.011 | |
| No other health courses 1 | 33 | 32.20 | ||||
| During high COVID incidences 2 | 14 | 33.04 | 0.809 | −0.242 | 0.030 | |
| Outside high COVID incidences 2 | 49 | 31.70 | ||||
| Δ BMI B0-F4 | Prepayment 130€ | 11 | 28.18 | 0.771 | −0.291 | 0.038 |
| No costs | 47 | 29.81 | ||||
| Usage of other health apps | 11 | 33.09 | 0.428 | −0.792 | 0.104 | |
| No other health apps | 47 | 28.66 | ||||
| Other health courses 1 | 21 | 33.48 | 0.172 | −1.365 | 0.179 | |
| No other health courses 1 | 37 | 27.24 | ||||
| During high COVID incidences 2 | 17 | 30.18 | 0.843 | −0.199 | 0.026 | |
| Outside high COVID incidences 2 | 41 | 29.22 | ||||
| Δ BMI B0-F6 | Prepayment 130€ | 11 | 30.18 | 0.522 | −0.640 | 0.087 |
| No costs | 43 | 26.81 | ||||
| Usage of other health apps | 10 | 28.20 | 0.875 | −0.158 | 0.022 | |
| No other health apps | 44 | 27.34 | ||||
| Other health courses 1 | 23 | 29.80 | 0.349 | −0.937 | 0.128 | |
| No other health courses 1 | 31 | 25.79 | ||||
| During high COVID incidences 2 | 15 | 29.40 | 0.578 | −0.556 | 0.076 | |
| Outside high COVID incidences 2 | 39 | 26.77 | ||||
| Δ BMI B0-F12 | Prepayment 130€ | 9 | 20.39 | 0.782 | −0.277 | 0.045 |
| No costs | 29 | 19.22 | ||||
| Usage of other health apps | 10 | 21.70 | 0.463 | −0.734 | 0.119 | |
| No other health apps | 28 | 18.71 | ||||
| Other health courses 1 | 10 | 17.00 | 0.404 | −0.834 | 0.136 | |
| No other health courses 1 | 28 | 20.39 | ||||
| During high COVID incidences 2 | 14 | 24.64 | 0.028 | −2.193 | 0.356 | |
| Outside high COVID incidences 2 | 24 | 16.50 |
Notes: 1 = Other health courses within the last six months at the time of baseline; 2 = High incidences appeared in March to April 2020 and November 2020 to February 2021. Abbreviations: B0 = baseline; F0 = end of intervention; F2 = two months after the intervention; F4 = four months after the intervention; F6 = six months after the intervention; F12 = twelve months after the intervention; Δ = difference between two measurement points.
Summary of the measurements used in this follow-up study, based on the study-protocol [24].
| Tool | Validation | Content | Items |
|---|---|---|---|
| General data | self-validated 1 | Author-constructed questions about sociodemographic data, individual backgrounds, BMI, endurance, and muscle strength [ | 5–12 |
| GPAQ [ | validated [ | The Global Physical Activity Questionnaire measures the intensity and duration of physical activity at work, during transport, and during leisure time. The data are quantified by a conversion into MET minutes per week. One metabolic equivalent represents the energy consumption at rest. The GPAQ defines 4 METs for moderate activity and 8 METs for vigorous activity [ | 16 |
| SF-8 [ | validated [ | The Short Form Health Survey 8 measures physical and mental health related quality of life and covers the eight dimensions of SF-36 on the basis of eight questions: physical functioning (PF), role-physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role-emotional (RE), and mental health (MH). | 8 |
| Process evaluation | self-validated 1 | Author-constructed question to assess the motivation of participants to further use different contents of the app after completion of the program [ | 1 |
| Sustainability | self-validated 1 | Author-constructed questions to assess the use of the exercises and components of the program after it has been completed [ | 5 |
1 see Section 2.5. Preliminary evaluative measures. Abbreviations: GPAQ = Global Physical Activity Questionnaire; SF-8 = Short Form Health Survey 8.
Characteristics of the study participant with different baseline activity levels.
| <3000 MET-Min/Week | ≥3000 MET-Min/Week | |
|---|---|---|
|
| 34 | 30 |
|
| ||
| female | 85.3 (29) | 76.7 (23) |
| male | 14.7 (5) | 23.3 (7) |
|
| ||
| Mean, Median | 43.74, 42.00 | 55.23, 58.00 |
|
| ||
| Married | 44.1 (15) | 73.3 (22) |
| Living in a stable relationship | 26.5 (9) | - |
| Divorced or separated | 14.7 (5) | 10.0 (3) |
| Single | 8.8 (3) | 13.3 (4) |
| Widowed | 2.9 (1) | 3.3 (1) |
| Other | 2.9 (1) | - |
|
| ||
| University degree | 52.9 (18) | 20.0 (6) |
| Completed vocational training | 20.6 (7) | 46.7 (14) |
| High school (12 years or more) | 11.8 (4) | 10.0 (3) |
| Secondary school (10 or 11 years) | 11.8 (4) | 16.7 (5) |
| Main school (9 years or less) | - | 3.3 (1) |
| Other | 2.9 (1) | 3.3 (1) |
|
| ||
| Full-time | 52.9 (18) | 40.0 (12) |
| Half-time | 14.7 (5) | 13.3 (4) |
| Part-time | 5.9 (2) | 10.0 (3) |
| Not employed | 17.6 (6) | 3.3 (1) |
| Retired | 8.8 (3) | 33.3 (10) |
|
| ||
| Mean (SD) | 124.62 (98.28) | 153.27 (102.88) |
| Median (IQR) | 67.00 (126.25) | 129.50 (159.50) |
| 25% quantile | 56.50 | 58.50 |
| 75% quantile | 182.75 | 218.00 |
|
| ||
| Health insurance | 23.5 (8) | 3.3 (1) |
| Doctor | 2.9 (1) | - |
| Internet | 14.7 (5) | 16.7 (5) |
| Social environment | 14.7 (5) | 16.7 (5) |
| Others | 44.1 (15) | 63.3 (19) |
|
| 44.1 (15) | 50.0 (15) |
|
| 20.6 (7) | 23.3 (7) |
|
| ||
| AOK PLUS, AOK Rheinland/Hamburg 3 | 79.4 (27) | 90.0 (27) |
| Other statutory insurance 4 | 17.6 (6) | 6.7 (2) |
| Private insurance 4 | 2.9 (1) | 3.3 (1) |
1 about the app “VIDEA bewegt”; 2 interventions other than „VIDEA bewegt“; 3 German statutory insurances where users could participate in the app for free; 4 other German insurances where users had to pay 130€ in advance and were reimbursed part of the course cost after completing the program.
Changes in body weight depending on the baseline weight 1.
| B0 | F0 | F2 | F4 | F6 | F12 | ||
|---|---|---|---|---|---|---|---|
| All |
| 64 | 64 | 63 | 60 | 58 | 46 |
| weight [kg], mean | 76.77 | 75.42 | 75.44 | 75.23 | 75.03 | 74.54 | |
| (SD) | (16.71) | (16.07) | (15.24) | (15.53) | (15.08) | (16.04) | |
| weight [kg], median | 75.00 | 74.00 | 75.00 | 74.50 | 75.00 | 73.00 | |
| 25% quantile | 63.00 | 62.00 | 62.00 | 62.50 | 62.00 | 60.75 | |
| 75% quantile | 89.25 | 84.75 | 87.00 | 85.00 | 85.25 | 85.25 | |
| Δ weight [kg], mean (SD) | −1.34 | −1.63 | −1.57 | −1.89 | −60.63 | ||
| (3.22) | (3.29) | (3.58) | (3.76) | (4.73) | |||
| Δ weight [kg], median | −1.00 | −1.00 | −1.00 | −1.00 | 0.00 3 | ||
| 25% quantile | −2.00 | −3.00 | −3.70 | −4.50 | −2.50 | ||
| 75% quantile | 0.00 | 0.00 | 0.00 | 0.00 | 2.00 | ||
| Wilcoxon 2 | |||||||
|
| <0.001 | <0.001 | 0.002 | <0.001 | 0.644 | ||
| z | −3.613 | −3.782 | −3.157 | −3.547 | −0.462 | ||
| r | 0.452 | 0.476 | 0.408 | 0.466 | 0.068 | ||
| Normal weight at B0 |
| 29 | 29 | 28 | 27 | 25 | 23 |
| weight [kg], mean | 63.48 | 63.41 | 63.43 | 63.52 | 63.40 | 63.74 | |
| (SD) | (8.73) | (8.89) | (8.95) | (9.31) | (9.15) | (9.36) | |
| weight [kg], median | 62.00 | 61.00 | 61.50 | 62.00 | 62.00 | 61.00 | |
| 25% quantile | 55.50 | 56.50 | 56.25 | 55.00 | 55.00 | 56.00 | |
| 75% quantile | 71.50 | 71.50 | 71.50 | 72.00 | 71.00 | 73.00 | |
| Δ weight [kg], mean (SD) | −0.07 | −0.29 | −0.19 | −0.28 | 0 | ||
| (1.22) | (1.33) | (1.73) | (1.31) | (2.04) | |||
| Δ weight [kg], median | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| 25% quantile | −1.00 | −1.00 | −2.00 | −1.00 | −1.00 | ||
| 75% quantile | 0.00 | 0.00 | 0.00 | 0.00 | 2.00 | ||
| Wilcoxon 2 | |||||||
|
| 0.700 | 0.237 | 0.454 | 0.268 | 0.896 | ||
| z | −0.386 | −1.182 | −0.749 | −1.109 | −0.131 | ||
| r | 0.072 | 0.223 | 0.144 | 0.222 | 0.065 | ||
| Overweight |
| 16 | 16 | 16 | 16 | 16 | 11 |
| weight [kg], mean | 77.75 | 75.75 | 77.19 | 76.38 | 76.50 | 77.00 | |
| (SD) | (6.25) | (7.22) | (7.57) | (7.10) | (7.53) | (9.47) | |
| weight [kg], median | 76.00 | 74.00 | 74.50 | 74.50 | 75.50 | 73.00 | |
| 25% quantile | 74.00 | 70.50 | 72.25 | 72.25 | 71.50 | 70.00 | |
| 75% quantile | 82.75 | 81.75 | 85.75 | 83.75 | 83.00 | 86.00 | |
| Δ weight [kg], mean (SD) | −2.00 | −0.56 | −1.38 | −1.25 | 0.09 | ||
| (5.11) | (3.50) | (3.63) | (4.74) | (7.11) | |||
| Δ weight [kg], median | −1.50 | −1.50 | −1.00 | −1.00 | 0.00 | ||
| 25% quantile | −4.75 | −3.00 | −4.75 | −4.50 | −4.00 | ||
| 75% quantile | 0.00 | 1.75 | 0.75 | 2.25 | 5.00 | ||
| Wilcoxon 2 | |||||||
|
| 0.051 | 0.240 | 0.129 | 0.309 | 0.798 | ||
| z | −1.953 | −1.175 | −1.517 | −1.018 | −0.256 | ||
| r | 0.488 | 0.294 | 0.379 | 0.254 | 0.077 | ||
| Obesity at B0 |
| 19 | 19 | 19 | 17 | 16 | 12 |
| weight [kg], mean | 96.21 | 93.47 | 91.68 | 92.76 | 91.94 | 93.00 | |
| (SD) | (11.93) | (12.68) | (11.24) | (11.89) | (11.84) | (13.22) | |
| weight [kg], median | 94.0 | 90.0 | 91.0 | 92.0 | 89.5 | 93.0 | |
| 25% quantile | 90.0 | 84.0 | 84.0 | 84.0 | 83.5 | 83.5 | |
| 75% quantile | 99.0 | 94.0 | 94.0 | 95.0 | 95.5 | 95.0 | |
| Δ weight [kg], mean (SD) | −2.74 | −4.53 | −3.94 | −5.06 | −2.50 | ||
| −2.68 | −3.42 | −4.55 | −3.49 | −5.68 | |||
| Δ weight [kg], median | −2.00 | −5.00 | −4.00 | −6.00 | −1.00 | ||
| 25% quantile | −5.00 | −7.00 | −6.50 | −6.75 | −7.00 | ||
| 75% quantile | 0.00 | −2.00 | −1.50 | −2.00 | 2.00 | ||
| Wilcoxon 2 | |||||||
|
| 0.001 | <0.001 | 0.006 | <0.001 | 0.212 | ||
| z | −3.222 | −3.609 | −2.771 | −3.313 | 1.248 | ||
| r | 0.739 | 0.823 | 0.672 | 0.828 | 0.938 |
1 normal weight: BMI < 15 kg/m2, overweight: BMI = 25.00–29.99 kg/m2, obesity: BMI > 30 kg/m2; 2 Wilcoxon signed-rank test between B0 and the follow-up measurements points; 3 a possible explanation for this result is that the study participants who have already completed the follow-up study had a lower BMI than the total sample. Abbreviations: B0 = baseline; F0 = end of intervention; F2 = two months after the intervention; F4 = four months after the intervention; F6 = six months after the intervention; F12 = twelve months after the intervention; Δ = changes in weight compared to B0; r = effect size.